1,158
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Osteogenic Differentiation of Human Mesenchymal Stem Cells Cultured with Dexamethasone, Vitamin D3, Basic Fibroblast Growth Factor, and Bone Morphogenetic Protein-2

, , , , , & show all
Pages 117-131 | Received 01 Jun 2011, Accepted 03 Aug 2011, Published online: 03 Oct 2011

REFERENCES

  • Waite, P.D., and Waite, D.E. (1996). Bone grafting for the alveolar cleft defect. Semin. Orthod. 2:192–196.
  • Moreau, J.L., Caccamese, J.F., Coletti, D.P., Sauk, J.J., and Fisher, J.P. (2007). Tissue engineering solutions for cleft palates. J. Oral. Maxillofac. Surg. 65:2503–2511.
  • Zuk, P.A. (2008). Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? Pediatr. Res. 63:478–486.
  • Logeart-Avramoglou, D., Anagnostou, F., Bizios, R., and Petite, H. (2005). Engineering bone: Challenges and obstacles. J. Cell Mol. Med. 9:72–84.
  • Rickard, D.J., Sullivan, T.A., Shenker, B.J., Leboy, P.S., and Kazhdan, I. (1994). Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev. Biol. 161:218–228.
  • Jorgensen, N.R., Henriksen, Z., Sorensen, O.H., and Civitelli, R. (2004). Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: Validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69:219–226.
  • Deifenderfer, D.L., Osyczka, A.M., Reilly, G.C., and Leboy, P.S. (2003). BMP responsiveness in human mesenchymal stem cells. Connect. Tissue Res. 44:305–311.
  • Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. (1997). Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell Biochem. 64:295–312.
  • Hanada, K., Dennis, J.E., and Caplan, A.I. (1997). Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 12:1606–1614.
  • Wang, L., Huang, Y., Pan, K., Jiang, X., and Liu, C. (2010). Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation. Ann. Biomed. Eng. 38:77–87.
  • Takita, H., Tsuruga, E., Ono, I., and Kuboki, Y. (1997). Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. Eur. J. Oral Sci. 105:588–592.
  • Fujimura, K., Bessho, K., Okubo, Y., Kusumoto, K., Segami, N., and Iizuka, T. (2002). The effect of fibroblast growth factor-2 on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in rat muscle. Arch. Oral Biol. 47:577–584.
  • van Driel, M., Pols, H.A., and van Leeuwen, J.P. (2004). Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr. Pharm. Des. 10:2535–2555.
  • Beresford, J.N., Joyner, C.J., Devlin, C., and Triffitt, J.T. (1994). The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch. Oral Biol. 39:941–947.
  • van Driel, M., Koedam, M., Buurman, C.J., Roelse, M., Weyts, F., Chiba, H., Uitterlinden, A.G., Pols, H.A., and van Leeuwen, J.P. (2006). Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J. Cell Biochem. 99:922–935.
  • Kirsch, T., Nickel, J., and Sebald, W. (2000). B.M.P.-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. Embo. J. 19:3314–3324.
  • Ruppert, R., Hoffmann, E., and Sebald, W. (1996). Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237:295–302.
  • Frank, O., Heim, M., Jakob, M., Barbero, A., Schafer, D., Bendik, I., Dick, W., Heberer, M., and Martin, I. (2002). Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J. Cell. Biochem. 85:737–746.
  • Anderson, H.C. (1989). Mechanism of mineral formation in bone. Lab. Invest. 60:320–330.
  • Varkey, M., Kucharski, C., Doschak, M.R., Winn, S.R., Brochmann, E.J., Murray, S., Matyas, J.R., Zernicke, R.F., and Uludag, H. (2007). Osteogenic response of bone marrow stromal cells from normal and ovariectomized rats treated with a low dose of basic fibroblast growth factor. Tissue Eng. 13:809–817.
  • Fromigue, O., Marie, P.J., and Lomri, A. (1997). Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine 9:613–623.
  • Chaudhary, L.R., Hofmeister, A.M., and Hruska, K.A. (2004). Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 34:402–411.
  • Kim, I.S., Song, Y.M., Cho, T.H., Park, Y.D., Lee, K.B., Noh, I., Weber, F., and Hwang, S.J. (2008). In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation. Dev. Growth Differ. 50:553–564.
  • Piek, E., Sleumer, L.S., van Someren, E.P., Heuver, L., de Haan, J.R., de Grijs, I., Gilissen, C., Hendriks, J.M., van Ravestein-van Os, R.I., Bauerschmidt, S., Dechering, K.J., and van Zoelen, E.J. (2010). Osteo-transcriptomics of human mesenchymal stem cells: Accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis. Bone 46(3):613–627.
  • Donahue, H.J., Li, Z., Zhou, Z., and Yellowley, C.E. (2000). Differentiation of human fetal osteoblastic cells and gap junctional intercellular communication. Am. J. Physiol. Cell Physiol. 278:C315–C22.
  • Hankemeier, S., Keus, M., Zeichen, J., Jagodzinski, M., Barkhausen, T., Bosch, U., Krettek, C., and Van Griensven, M. (2005). Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: Potential implications for tissue engineering of tendons and ligaments. Tissue Eng. 11:41–49.
  • Varkey, M., Kucharski, C., Haque, T., Sebald, W., and Uludag, H. (2006). In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin. Orthop. Relat. Res. 443:113–123.
  • Nuttall, M.E., Patton, A.J., Olivera, D.L., Nadeau, D.P., and Gowen, M. (1998). Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J. Bone Miner. Res. 13:371–382.
  • Bernlohr, D.A., Angus, C.W., Lane, M.D., Bolanowski, M.A., and Kelly Jr., T.J. (1984). Expression of specific mRNAs during adipose differentiation: Identification of an mRNA encoding a homologue of myelin P2 protein. Proc. Natl. Acad. Sci. USA. 81:5468–5472.
  • Ross, S.R., Graves, R.A., Greenstein, A., Platt, K.A., Shyu, H.L., Mellovitz, B., and Spiegelman, B.M. (1990). A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc. Natl. Acad. Sci. USA. 87:9590–9594.
  • Bellows, C.G., Wang, Y.H., Heersche, J.N., and Aubin, J.E. (1994). 1,25-dihydroxyvitamin D3 stimulates adipocyte differentiation in cultures of fetal rat calvaria cells: Comparison with the effects of dexamethasone. Endocrinology 134:2221–2229.
  • Mikami, Y., Lee, M., Irie, S., and Honda, M.J. (2011). Dexamethasone modulates osteogenesis and adipogenesis with regulation of osterix expression in rat calvaria-derived cells. J. Cell. Physiol. 226:739–748.
  • Shen, B., Wei, A., Whittaker, S., Williams, L.A., Tao, H., Ma, D.D.F., and Diwan, A.D. (2010). The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J. Cell Biochem. 109:406–416.
  • Neumann, K., Endres, M., Ringe, J., Flath, B., Manz, R., Haupl, T., Sittinger, M., and Kaps, C. (2007). BMP7 promotes adipogenic but not osteo-/chondrogenic differentiation of adult human bone marrow-derived stem cells in high-density micro-mass culture. J. Cell Biochem. 102:626–637.
  • Akita, S., Fukui, M., Nakagawa, H., Fujii, T., and Akino, K. (2004). Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen. 12:252–259.
  • Prockop, D.J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74.
  • Komori, T. (2010). Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 339:189–195.
  • Setzer, B., Bachle, M., Metzger, M.C., and Kohal, R.J. (2009). The gene-expression and phenotypic response of hFOB 1.19 osteoblasts to surface-modified titanium and zirconia. Biomaterials 30:979–990.
  • Titorencu, I., Jinga, V.V., Constantinescu, E., Gafencu, A.V., Ciohodaru, C., Manolescu, I., Zaharia, C., and Simionescu, M. (2007). Proliferation, differentiation and characterization of osteoblasts from human BM mesenchymal cells. Cytotherapy 9:682–696.
  • Mankani, M.H., Kuznetsov, S.A., Wolfe, R.M., Marshall, G.W., and Robey, P.G. (2006). In vivo bone formation by human bone marrow stromal cells: Reconstruction of the mouse calvarium and mandible. Stem Cells 24:2140–2149.
  • Bidic, S.M., Calvert, J.W., Marra, K., Kumta, P., Campbell, P., Mitchell, R., Wigginton, W., Hollinger, J.O., Weiss, L., and Mooney, M.P. (2003). Rabbit calvarial wound healing by means of seeded Caprotite scaffolds. J. Dent. Res. 82:131–135.
  • Burastero, G., Scarfì, S., Ferraris, C., Fresia, C., Sessarego, N., Fruscione, F., Monetti, F., Scarfò, F., Schupbach, P., Podestà, M., Grappiolo, G., and Zocchi, E. (2010). The association of human mesenchymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats. Bone 47(1):117–126.
  • Gimbel, M., Ashley, R.K., Sisodia, M., Gabbay, J.S., Wasson, K.L., Heller, J., Wilson, L., Kawamoto, H.K., and Bradley, J.P. (2007). Repair of alveolar cleft defects: Reduced morbidity with bone marrow stem cells in a resorbable matrix. J. Craniofac. Surg. 18:895–901.
  • Behnia, H., Khojasteh, A., Soleimani, M., Tehranchi, A., Khoshzaban, A., Keshel, S.H., and Atashi, R. (2009). Secondary repair of alveolar clefts using human mesenchymal stem cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 108:e1–6.
  • Hibi, H., Yamada, Y., Ueda, M., and Endo, Y. (2006). Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int. J. Oral Maxillofac. Surg. 35:551–555.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.